NBIXbenzinga

Neurocrine Biosciences Phase 3 KINECT-4 Post Hoc Analysis Demonstrates Clinically Meaningful And Sustained Improvement In Tardive Dyskinesia With Long-Term Use Of INGREZZA Capsules

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 21, 2024 by benzinga